Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Curr Opin HIV AIDS. 2016 Nov;11(6):569–575. doi: 10.1097/COH.0000000000000317

Table 1.

Pathway to eliciting broadly neutralizing antibodies through vaccination: recent developments

Challenges Proposed solutions
Kickstart bNAb precursors Rare, frequently autoreactive, and may not bind HV Env Engineer germline-reactive immunogens
Screen for germline-reactive natural Env
Measure early indicators of success (e.g. antibody allele, angle of approach)
Elicit Tier-2 nAbs and drive them towards breadth Native-like HIV Env immunogens needed, off-target responses to glycan holes are common, breadth may require extensive SHM and tolerance of epitope diversity/glycans SOSIP and other trimer platforms (e.g. NFL-trimers and trimer-enriched VLPs)
Immunogen redesign to reduce off-target neutralization
B cell-lineage based immunogens
Cocktails
Replicating vectors for persisting antigen